Provided by Tiger Trade Technology Pte. Ltd.

Evolent Health

3.90
-0.0600-1.52%
Volume:1.97M
Turnover:7.84M
Market Cap:438.68M
PE:-0.83
High:4.14
Open:3.98
Low:3.88
Close:3.96
52wk High:12.07
52wk Low:2.10
Shares:112.48M
Float Shares:93.95M
Volume Ratio:0.62
T/O Rate:2.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7089
EPS(LYR):-5.0732
ROE:-65.11%
ROA:-0.45%
PB:1.11
PE(LYR):-0.77

Loading ...

Evolent Health Inc. Files Initial Statement of Beneficial Ownership for Chief Financial Officer Mario Ramos

Reuters
·
Jan 06

BRIEF-Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08

Reuters
·
Jan 03

Evolent Reports Inducement Award Under Nyse Listing Rule 303a.08

THOMSON REUTERS
·
Jan 03

Syra Health Names Gregory R. Alexander as CEO

Reuters
·
Dec 18, 2025

Evolent Health Inc. Files Initial Beneficial Ownership Statement for Director Jill D. Smith

Reuters
·
Dec 13, 2025

Evolent Health Closes Privia Management Company Acquisition

Reuters
·
Dec 08, 2025

Evolent Health Inc : Piper Sandler Cuts Target Price to $6 From $18

THOMSON REUTERS
·
Dec 02, 2025

Evolent Health Inc - Reaffirms Q4 2025 Revenue Guidance - SEC Filing

THOMSON REUTERS
·
Dec 02, 2025

Evolent Health Inc - Reaffirms Q4 2025 Adj Ebitda Guidance - SEC Filing

THOMSON REUTERS
·
Dec 02, 2025

Evolent Health Announces Retirement of Director Cheryl Scott and Appointment of Independent Director Smith

Reuters
·
Dec 02, 2025

Canaccord Genuity Keeps Their Buy Rating on Evolent Health (EVH)

TIPRANKS
·
Nov 25, 2025

Evolent Health Is Maintained at Buy by Citigroup

Dow Jones
·
Nov 22, 2025

Director’s Bold Move: Major Stock Purchase Signals Confidence in Evolent Health

TIPRANKS
·
Nov 20, 2025

Evolent Health Director Brendan B. Springstubb Reports Acquisition of Common Shares

Reuters
·
Nov 20, 2025

Evolent Health Q3 Revenue USD 479.533 Million Vs. IBES Estimate USD 467.5 Million

Reuters
·
Nov 20, 2025

Evolent Health Is Maintained at Overweight by JP Morgan

Dow Jones
·
Nov 18, 2025